HRT Financial’s Eli Lilly LLY Stock Holding History

HRT Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.53M	Sell	7,100 -92,300	-93%	-$93.6M	0.02%	842
2025 Q4	$107M	Buy	99,400 +74,400	+298%	+$71.1M	0.34%	38
2025 Q3	$19.1M	Sell	25,000 -46,600	-65%	-$34.7M	0.07%	199
2025 Q2	$55.8M	Buy	71,600 +37,400	+109%	+$29.1M	0.25%	48
2025 Q1	$28.2M	Buy	34,200 +26,700	+356%	+$22.2M	0.18%	75
2024 Q4	$5.79M	Sell	7,500 -6,600	-47%	-$5.46M	0.03%	356
2024 Q3	$12.5M	Buy	+14,100	New	+$12.7M	0.06%	198
2024 Q1	–	Sell	-500	Closed	-$291K	–	2742
2023 Q4	$291K	Sell	500 -400	-44%	-$233K	﹤0.01%	1635
2023 Q3	$483K	Sell	900 -800	-47%	-$412K	﹤0.01%	1421
2023 Q2	$797K	Sell	1,700 -16,000	-90%	-$6.71M	0.01%	1087
2023 Q1	$6.08M	Buy	17,700 +13,600	+332%	+$4.59M	0.07%	215
2022 Q4	$1.5M	Sell	4,100 -1,800	-31%	-$638K	0.02%	728
2022 Q3	$1.91M	Buy	+5,900	New	+$1.87M	0.02%	618
2022 Q1	–	Sell	-1,100	Closed	-$303K	–	3510
2021 Q4	$303K	Buy	+1,100	New	+$279K	﹤0.01%	2267

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HRT Financial's LLY Position: Q1 2026 in Review

HRT Financial reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $6.93M and leaving 53,051 shares worth $48.8M. The position accounts for 0.12% of the portfolio, ranked #131.

HRT Financial first reported a position in LLY in Q4 2017 and has held it in 22 quarters since. The position peaked at $186M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

HRT Financial held 53,051 shares of Eli Lilly worth $48.8M as of Q1 2026.
HRT Financial sold 6,838 Eli Lilly shares in Q1 2026, an estimated $6.93M.
Eli Lilly made up 0.12% of HRT Financial's portfolio in Q1 2026, its #131 holding.
HRT Financial first reported a position in Eli Lilly in Q4 2017 and has held it in 22 quarters since.
HRT Financial's Eli Lilly position peaked at $186M in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.